Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oxidized phospholipids and lipoprotein(a): An update.
Koutsogianni AD, Liberopoulos E, Tellis K, Tselepis AD. Koutsogianni AD, et al. Among authors: tselepis ad. Eur J Clin Invest. 2022 Apr;52(4):e13710. doi: 10.1111/eci.13710. Epub 2021 Nov 27. Eur J Clin Invest. 2022. PMID: 34837383 Review.
Lipid profile in patients with microvascular angina.
Tselepis AD, Elisaf M, Goudevenos J, Tselegaridis T, Bairaktari E, Siamopoulos KC, Sideris D. Tselepis AD, et al. Eur J Clin Invest. 1996 Dec;26(12):1150-5. doi: 10.1046/j.1365-2362.1996.520609.x. Eur J Clin Invest. 1996. PMID: 9013091
Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
Karabina SA, Elisaf M, Bairaktari E, Tzallas C, Siamopoulos KC, Tselepis AD. Karabina SA, et al. Among authors: tselepis ad. Eur J Clin Invest. 1997 Jul;27(7):595-602. doi: 10.1046/j.1365-2362.1997.1570706.x. Eur J Clin Invest. 1997. PMID: 9263748
The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease.
Lourida ES, Papathanasiou AI, Goudevenos JA, Tselepis AD. Lourida ES, et al. Among authors: tselepis ad. Prostaglandins Leukot Essent Fatty Acids. 2006 Aug;75(2):117-26. doi: 10.1016/j.plefa.2006.03.012. Epub 2006 Jul 14. Prostaglandins Leukot Essent Fatty Acids. 2006. PMID: 16843649
The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome.
Filippatos TD, Gazi IF, Liberopoulos EN, Athyros VG, Elisaf MS, Tselepis AD, Kiortsis DN. Filippatos TD, et al. Among authors: tselepis ad. Atherosclerosis. 2007 Aug;193(2):428-37. doi: 10.1016/j.atherosclerosis.2006.07.010. Epub 2006 Sep 5. Atherosclerosis. 2007. PMID: 16911813 Clinical Trial.
The effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndrome.
Filippatos TD, Liberopoulos EN, Kostapanos M, Gazi IF, Papavasiliou EC, Kiortsis DN, Tselepis AD, Elisaf MS. Filippatos TD, et al. Among authors: tselepis ad. Diabetes Obes Metab. 2008 Jun;10(6):476-83. doi: 10.1111/j.1463-1326.2007.00733.x. Epub 2007 Apr 24. Diabetes Obes Metab. 2008. PMID: 17459096 Clinical Trial.
274 results